Article
Total Bilirubin Levels Predict Subclinical Atherosclerosis in Patients With Prediabetes
Angiology 1-7 ª The Author(s) 2016 Reprints and permission: sagepub.com/journalsPermissions.nav DOI: 10.1177/0003319716632394 ang.sagepub.com
Hikmet Hamur, MD1, Hakan Duman, MD2, Levent Demirtas, MD3, Eftal Murat Bakirci, MD1, Murtaza Emre Durakoglugil, MD2, Husnu Degirmenci, MD1, Kamuran Kalkan, MD4, Erkan Yildirim, MD4, and Ertan Vuruskan, MD5
Abstract Bilirubin may have important antiatherosclerotic effects. Prediabetes (PD), the intermediate stage before diabetes mellitus, is associated with increased cardiovascular morbidity and mortality. We evaluated the relationship between serum bilirubin levels and carotid intima–media thickness (cIMT), as a surrogate marker of subclinical atherosclerosis, in patients with PD. We enrolled 170 consecutive patients with PD. The patients underwent ultrasonography to evaluate cIMT. The patients were divided into groups according to cIMT values (
Total Bilirubin Levels Predict Subclinical Atherosclerosis in Patients With Prediabetes
Angiology 1-7 ª The Author(s) 2016 Reprints and permission: sagepub.com/journalsPermissions.nav DOI: 10.1177/0003319716632394 ang.sagepub.com
Hikmet Hamur, MD1, Hakan Duman, MD2, Levent Demirtas, MD3, Eftal Murat Bakirci, MD1, Murtaza Emre Durakoglugil, MD2, Husnu Degirmenci, MD1, Kamuran Kalkan, MD4, Erkan Yildirim, MD4, and Ertan Vuruskan, MD5
Abstract Bilirubin may have important antiatherosclerotic effects. Prediabetes (PD), the intermediate stage before diabetes mellitus, is associated with increased cardiovascular morbidity and mortality. We evaluated the relationship between serum bilirubin levels and carotid intima–media thickness (cIMT), as a surrogate marker of subclinical atherosclerosis, in patients with PD. We enrolled 170 consecutive patients with PD. The patients underwent ultrasonography to evaluate cIMT. The patients were divided into groups according to cIMT values (
